|
|
|
NAFLD
https://www.ncbi.nlm.nih.gov/pubmed/31134334 NAFLD
J Gastroenterol. 2019 May 27. doi: 10.1007/s00535-019-01594-6. [Epub ahead of print]
Nonalcoholic fatty liver disease is associated with lower hepatitis B viral load and antiviral response in pediatric population.
Wang L1,2, Wang Y3, Liu S2, Zhai X1, Zhou G2, Lu F4, Zhao J5.
Abstract
BACKGROUND:
The interaction between nonalcoholic fatty liver disease (NAFLD) and chronic hepatitis B infection (CBI) was unclear. We aimed to investigate the association between NAFLD and CBI and the effect of NAFLD on response to antiviral therapy in pediatric population.
METHODS:
https://pubmed.ncbi.nlm.nih.gov/35560106/ NAFLD
Hepatology. 2022 May 13.
doi: 10.1002/hep.32570. Online ahead of print.
Nonalcoholic Fatty Liver Disease Risk and Histologic Severity are Associated with Genetic Polymorphisms in Children
Nidhi P Goyal 1 2, Sara B Rosenthal 3, Chanod Nasamran 3, Cynthia A Behling 4, Jorge E Angeles 1, Mark H Fishbein 5, Kathryn E Harlow 6, Ajay K Jain 7, Jean P Molleston 8, Kimberly P Newton 1 2, Patricia Ugalde-Nicalo 1, A Xanthankos 9, Katherine Yates 10, Nicholas J Schork 11 12, Kathleen M Fisch 3, Jeffrey B Schwimmer 1 2, N. A. S. H. Clinical Research Network
Abstract
https://www.ncbi.nlm.nih.gov/pubmed/30335007 NAFLD
Medicine (Baltimore). 2018 Oct;97(42):e12879. doi: 10.1097/MD.0000000000012879.
Nonalcoholic fatty liver disease with prolactin-secreting pituitary adenoma in an adolescent: A case report.
Takaki Y1, Mizuochi T, Nishioka J, Eda K, Yatsuga S, Yamashita Y.
Abstract
RATIONALE:
Nonalcoholic fatty liver disease (NAFLD), among the commonest chronic liver disorders in children and adolescents, is considered a reflection of the current obesity epidemic in children and adults. This liver disease has been linked with various metabolic disorders, but not with prolactinoma (PRLoma).
PATIENT CONCERNS:
https://www.ncbi.nlm.nih.gov/pubmed/28472948
Ferraioli G, Calcaterra V, Lissandrin R, Guazzotti M, Maiocchi L, Tinelli C, De Silvestri A, Regalbuto C, Pelizzo G, Larizza D, Filice C. BMC Gastroenterol. 2017 May 4;17(1):61. doi: 10.1186/s12876-017-0617-6.
Abstract
BACKGROUND:
To assess the clinical validity of controlled attenuation parameter (CAP) in the diagnosis of hepatic steatosis in a series of overweight or obese children by using the imperfect gold standard methodology.
METHODS:
https://pubmed.ncbi.nlm.nih.gov/32715793/ NAFLD
Expert Rev Gastroenterol Hepatol. 2020 Sep 7;1-12.
Noninvasive diagnostic tools for pediatric NAFLD: where are we now?
Antonella Mosca 1, Nadia Panera 2, Annalisa Crudele 2, Anna Alisi 2
PMID: 32715793
DOI: 10.1080/17474124.2020.1801413
Full-text linksCite
Abstract
http://www.ncbi.nlm.nih.gov/pubmed/26049707
Korkmaz H, Unler GK, Gokturk HS, Schmidt WE, Kebapcilar L. Noninvasive estimation of disease activity and liver fibrosis in nonalcoholic fatty liver disease using anthropometric and biochemical characteristics, including insulin, insulin resistance, and 13C-methionine breath test. Eur J Gastroenterol Hepatol. 2015 Oct; 27(10):1137-43.
Abstract
OBJECTIVE:
The purpose of this study was to noninvasively estimate disease activity and liver fibrosis in patients with nonalcoholic fatty liver disease (NAFLD) using anthropometric and biochemical characteristics and the C-methionine breath test (MeBT).
METHODS:
https://www.ncbi.nlm.nih.gov/pubmed/30671426 NAFLD
Front Pediatr. 2019 Jan 8;6:416. doi: 10.3389/fped.2018.00416. eCollection 2018.
Novel Ultrasonographic Fatty Liver Indicator Can Predict Hepatitis in Children With Non-alcoholic Fatty Liver Disease.
Liu HK1, Yang MC1, Su YT1, Tai CM2, Wei YF2, Lin IC3, Tsai CC1.
Abstract
https://pubmed.ncbi.nlm.nih.gov/33030457/ NAFLD
Psychiatr Danub. 2020 Oct;32(Suppl 3):378-381.
Obesity and Pediatric Fatty Liver: The Silent Epidemic and Significant Health Problem
Nizama Salihefendić 1, Muharem Zildžić
http://www.ncbi.nlm.nih.gov/pubmed/24321532
Sundaram SS, Sokol RJ, Capocelli KE, Pan Z, Sullivan JS, Robbins K, Halbower AC. Obstructive sleep apnea and hypoxemia are associated with advanced liver histology in pediatric nonalcoholic fatty liver disease. J Pediatr. 2014 Apr; 164(4): 699-706.
Abstract
OBJECTIVE:
To determine whether obstructive sleep apnea (OSA) and/or nocturnal hypoxemia are associated with the severity of liver injury in patients with pediatric nonalcoholic fatty liver disease (NAFLD).
STUDY DESIGN:
https://www.ncbi.nlm.nih.gov/pubmed/30601174 NAFLD
Curr Opin Clin Nutr Metab Care. 2018 Dec 28. doi: 10.1097/MCO.0000000000000539. [Epub ahead of print]
Omega-3 fatty acids and nonalcoholic fatty liver disease in adults and children: where do we stand?
Spooner MH1, Jump DB.
Abstract
PURPOSE OF REVIEW:
SMS requests to
9224791366
Ask The Expert
Pediatric Liver Specialists in India
Centres offering Genetic Testing for Pediatric Liver Diseases
Financial Aid Offered by Trusts
